About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Combining Venoarterial Extracorporeal Membrane Oxygenation and Impella (ECPELLA) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO in Acute MI

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):11.

Promising First Results of a Newly Developed Percutaneous Left Ventricular Assist Device in a Large Animal Model of Cardiac Arrest

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):10.

Impaired Diastolic Function Predicts Improved Ischaemic Myocardial Flow Improvement with Mechanical Left Ventricular Unloading

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):9–10.

Effect of Impella RP Versus Vasoactive Treatment on Left Ventricular Strain in Cardiogenic Shock

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):8.